ArticleScientific reports2025
Factors affecting health-related quality of life following axillary lymph node dissection among breast cancer survivors in Egypt.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Axillary lymph node dissection (ALND) remains a standard component in the management of breast cancer; however, it may have lasting impacts on patients' health-related quality of life (HRQOL). This study aimed to assess HRQOL and identify its demographic and clinical correlates among breast cancer survivors who underwent ALND. This cross-sectional study was conducted among breast cancer survivors post-ALND at a tertiary oncology center in Alexandria, Egypt. HRQOL was measured using the Arabic FACT-B (version 4.0), and the associated factors were analyzed using multivariate analysis of variance (MANOVA). A total of 150 breast cancer survivors completed the FACT-B questionnaire, with a mean HRQOL score of 88.92 ± 18.01. Of the participants, 18.7% had poor, 64.0% had moderate, and 17.3% had good HRQOL. MANOVA showed that the type of surgery, BMI, HER2 status, lymph node involvement, and tumor stage were significantly associated with HRQOL (p < 0.05). Between-subject analyses and post hoc comparisons confirmed significant group differences across the FACT-B subscales. Overweight or obese participants had poorer Physical, Emotional, and Functional Well-Being. Mastectomy, HER2-positive status, and Stage III disease were associated with lower HRQOL across multiple domains, while lymph node involvement impacted the Physical Well-Being subscale only. Integrating routine HRQOL assessment into survivorship care is essential for identifying individuals at a higher risk of poor outcomes. Tailored follow-up strategies and supportive interventions for these subgroups can enhance the long-term well-being and improve the overall post-treatment quality of life of breast cancer survivors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.